Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. Thromb Haemost. 2016 07 04; 116(1):155-61.
View in:
PubMed
subject areas
Administration, Oral
Anticoagulants
Double-Blind Method
Factor Xa Inhibitors
Hemorrhage
Humans
Pyridines
Risk Factors
Thiazoles
Venous Thromboembolism
Vitamin K
Warfarin
authors with profiles
Gary E Raskob